EU provides further E22 million for war on HIV:
This article was originally published in Clinica
Executive Summary
The European Commission has increased by E22m ($21.5m) the funding allocated to fight HIV/AIDS in developing countries. Much of this will go improving access to, and the quality of, health services. The initiative is part of an EU drive to tackle poverty-related diseases, such as HIV/AIDS, malaria and tuberculosis. Developing countries account for some 95% of the estimated 40 million HIV-infected people worldwide and rising at a rate of 15,000 cases a day. Public health features high on the agenda of the EU's programme for sustainable development, which is the topic of a world summit, to be held in Johannesburg, South Africa, on August 28-September 4 2002.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.